Flightpath Biosciences, Inc.
PrivateLast Round
Series A
Oct 23, 2024
Est. Valuation
$19M
Total Funding Raised
$8.25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Flightpath Biosciences, Inc. is a biotechnology company that develops precision therapeutics targeting bacterial pathogens to treat infection-associated complex diseases while sparing the microbiome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flightpath Biosciences, Inc. Comparables
Compare Flightpath Biosciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| APY Therapeutics | 64% | |
| Tonix Pharmaceuticals Holding Corp. | 55% | |
| Tarsus Pharmaceuticals | 54% |
Flightpath Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 23, 2024 | ||||
| Seed | Mar 8, 2023 | ||||
| Accelerator | Feb 9, 2021 |
Flightpath Biosciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Steven & Alexandra Cohen Foundation | Series A |
| Ann Arbor SPARK | Series A |
| Northern Michigan Angels | Series A |
| Michigan Rise | Series A, Seed |
| Michigan Strategic Fund | Seed |
| ID Ventures | Series A |
| Bay Area Lyme Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 76% MoM.
- Oct 23, 2024
$8M round with participation from Steven & Alexandra Cohen Foundation.
Flightpath Biosciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Flightpath Biosciences, Inc.'s valuation, stock price, and market status.
Is Flightpath Biosciences, Inc. a public or private company?
Flightpath Biosciences, Inc. is a private company.
What is the current stock price of Flightpath Biosciences, Inc.?
Flightpath Biosciences, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Flightpath Biosciences, Inc. worth (valuation)?
Flightpath Biosciences, Inc.'s valuation is estimated at $19.0M based on funding round data.
Can I buy Flightpath Biosciences, Inc. stock?
Flightpath Biosciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Flightpath Biosciences, Inc.'s last funding round?
Flightpath Biosciences, Inc.'s most recent funding round was Series A on October 23, 2024.
Who are the main investors in Flightpath Biosciences, Inc.?
Key investors in Flightpath Biosciences, Inc. include Steven & Alexandra Cohen Foundation, Ann Arbor SPARK, Northern Michigan Angels, Michigan Rise, Bay Area Lyme Foundation.
Will Flightpath Biosciences, Inc. IPO soon?
No public IPO plans have been announced for Flightpath Biosciences, Inc..
How can I track Flightpath Biosciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Flightpath Biosciences, Inc.'s secondary market activity and sign up for updates.